Silver Book Fact

Investments in cancer care generated $598 billion of additional value for cancer patients diagnosed between 1983 and 1999.

Philipson, T, M Eber, D Lakdawalla, M Corral, R Conti, and D Goldman. An Analysis of Whether Higher Health Care Spending is ?Worth it? in the Case of Cancer. Health Affairs. 2012; 31(4): 667-75. http://content.healthaffairs.org/content/31/4/667.abstract

Reference

Title
An Analysis of Whether Higher Health Care Spending is ?Worth it? in the Case of Cancer
Publication
Health Affairs
Publication Date
2012
Authors
Philipson, T, M Eber, D Lakdawalla, M Corral, R Conti, and D Goldman
Volume & Issue
Volume 31, Issue 4
Pages
667-75
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Imatinib, the first chemical agent to target a cancer-specific protein, improved 5-year survival rates for chromosome-positive chronic myelogenous leukemia (CML) from 17% in the mid-1970s to 63% in 2007.  
  • Image-guided breast biopsy takes about 1/5 the of a surgical biopsy, reduces complications and allows women to commence daily activities in 1/2 the time that it takes after open surgery.…  
  • According to the Pharmaceutical Research and Manufacturers of America, a radiopharmaceutical currently in development is a synthetic version of a substance derived from scorpions–chlorotoxin. This could be a powerful…  
  • Between 1990/1991 and 2008, the overall cancer mortality rates decreased by 22.9 percent in men and 15.3 percent in women—around 1,024,400 deaths avoided—primarily due to reductions in tobacco use among…  
  • Thousands of potential cancer medicines in development